Ekocorp

Ekocorp FCF Growth

Year-over-Year Free Cash Flow Growth of Ekocorp (EKOCORP.NL) as of Oct 22, 2026.

FCF Growth

0.00

Last updated:

Year-over-Year Free Cash Flow Growth of Ekocorp is 2020 0.00 . Year-over-Year Free Cash Flow Growth of Ekocorp was 2019 -2,974.60 % . It decreases by % higher compared to the previous year.

The Ekocorp FCF Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Growth
Date
FCF Growth
Jan 1, 2016
107.41 NGN
Jan 1, 2017
-213.64 NGN
Jan 1, 2018
78.12 NGN
Jan 1, 2019
-2,974.60 NGN
Jan 1, 2020
0.00 NGN
The Ekocorp FCF Growth history
YEARFCF GrowthYoY
0.00-100.00%
-2,974.60 %-3,907.97%
78.12 %-136.56%
-213.64 %-298.89%
107.41 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ekocorp Stock analysis

What does Ekocorp do? Ekocorp PLC provides healthcare services through its segments including standalone facilities, capitation models, and strategic business units such as general outpatients, nursing, intensive care, medical, obstetrics and gynaecology, paediatrics, radiology, and surgery. The company offers specialized medical services like dietician, diabetic nurse educator, foot care specialist, and consultant ophthalmologist. Its consultant services encompass general surgery, orthopaedic surgery, grammatology, otorhinolaryngology, audiology, speech therapy, dental surgery, ophthalmology, radiology, physical medicine (Physiotherapy), endoscopy, anaesthesia, obstetrics and gynaecology, radiotherapy, and oncology. Ekocorp also provides immunological screening services including thyroid antibodies, thyroid adrenal anti-nuclear antibodies, and paediatric endocrinology. The firm targets patients seeking specialized medical care and preventive health services. Its services are delivered through its healthcare delivery model focused on standard medical care and anchor services. Ekocorp's strategic business units serve diverse patient needs across various medical specialties. The company's offerings include both outpatient and inpatient care through its structured segments. Ekocorp PLC's revenue streams come from medical service fees charged to patients and healthcare providers. The company generates income through its consultant services, specialized medical care, and immunological screening services. Its business model relies on delivering high-quality healthcare services across multiple specialties to a broad patient base. The firm's segments operate under a unified healthcare delivery framework that supports its service offerings. Ekocorp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ekocorp stock

On Eulerpool you can find the complete historical development of Year-over-Year Free Cash Flow Growth Ekocorp since 2006 – with annual values, charts, and detailed analysis.

FCF growth measures the percentage change in free cash flow. Growing FCF indicates improving cash generation capability.

To evaluate Year-over-Year Free Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Free Cash Flow Growth.

Year-over-Year Free Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Free Cash Flow Growth's Ekocorp historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Ekocorp

All Key Metrics — Ekocorp